Click for best price
TCell Therapy Market Size, Share 2023
The global T-Cell Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for T-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-Cell Therapy. This report contains market size and forecasts of T-Cell Therapy in global, including the following market information:
- Global T-Cell Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
CAR T Cell Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of T-Cell Therapy include Gilead Sciences, Inc., Sorrento Therapeutics, Fate Therapeutics Inc., Novartis International AG, AbbVie Inc., Adaptimmune Therapeutics PLC, Bluebird Bio, TCR2 Therapeutics, Inc. and Pfizer Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the T-Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global T-Cell Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global T-Cell Therapy Market Segment Percentages, by Type, 2022 (%)
- CAR T Cell Therapy
- TCR Therapy
- TIL Therapy
Global T-Cell Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global T-Cell Therapy Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Clinics & Ambulatory Centers
- Cancer Research Institutes
- Others
Global T-Cell Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global T-Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies T-Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies T-Cell Therapy revenues share in global market, 2022 (%)
key players include:
- Gilead Sciences, Inc.
- Sorrento Therapeutics
- Fate Therapeutics Inc.
- Novartis International AG
- AbbVie Inc.
- Adaptimmune Therapeutics PLC
- Bluebird Bio
- TCR2 Therapeutics, Inc.
- Pfizer Inc.
- DiaCarta, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of T-Cell Therapy, market overview.
Chapter 2: Global T-Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of T-Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of T-Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
T-Cell Therapy Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 T-Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global T-Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global T-Cell Therapy Overall Market Size
2.1 Global T-Cell Therapy Market Size: 2022 VS 2030
2.2 Global T-Cell Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top T-Cell Therapy Players in Global Market
3.2 Top Global T-Cell Therapy Companies Ranked by Revenue
3.3 Global T-Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 T-Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies T-Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 T-Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 T-Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 T-Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global T-Cell Therapy Market Size Markets, 2022 & 2030
4.1.2 CAR T Cell Therapy
4.1.3 TCR Therapy
4.1.4 TIL Therapy
4.2 By Type - Global T-Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global T-Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global T-Cell Therapy Revenue, 2024-2030
4.2.3 By Type - Global T-Cell Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global T-Cell Therapy Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics & Ambulatory Centers
5.1.4 Cancer Research Institutes
5.1.5 Others
5.2 By Application - Global T-Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global T-Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global T-Cell Therapy Revenue, 2024-2030
5.2.3 By Application - Global T-Cell Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global T-Cell Therapy Market Size, 2022 & 2030
6.2 By Region - Global T-Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global T-Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global T-Cell Therapy Revenue, 2024-2030
6.2.3 By Region - Global T-Cell Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America T-Cell Therapy Revenue, 2018-2030
6.3.2 US T-Cell Therapy Market Size, 2018-2030
6.3.3 Canada T-Cell Therapy Market Size, 2018-2030
6.3.4 Mexico T-Cell Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe T-Cell Therapy Revenue, 2018-2030
6.4.2 Germany T-Cell Therapy Market Size, 2018-2030
6.4.3 France T-Cell Therapy Market Size, 2018-2030
6.4.4 U.K. T-Cell Therapy Market Size, 2018-2030
6.4.5 Italy T-Cell Therapy Market Size, 2018-2030
6.4.6 Russia T-Cell Therapy Market Size, 2018-2030
6.4.7 Nordic Countries T-Cell Therapy Market Size, 2018-2030
6.4.8 Benelux T-Cell Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia T-Cell Therapy Revenue, 2018-2030
6.5.2 China T-Cell Therapy Market Size, 2018-2030
6.5.3 Japan T-Cell Therapy Market Size, 2018-2030
6.5.4 South Korea T-Cell Therapy Market Size, 2018-2030
6.5.5 Southeast Asia T-Cell Therapy Market Size, 2018-2030
6.5.6 India T-Cell Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America T-Cell Therapy Revenue, 2018-2030
6.6.2 Brazil T-Cell Therapy Market Size, 2018-2030
6.6.3 Argentina T-Cell Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa T-Cell Therapy Revenue, 2018-2030
6.7.2 Turkey T-Cell Therapy Market Size, 2018-2030
6.7.3 Israel T-Cell Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia T-Cell Therapy Market Size, 2018-2030
6.7.5 UAE T-Cell Therapy Market Size, 2018-2030
7 T-Cell Therapy Companies Profiles
7.1 Gilead Sciences, Inc.
7.1.1 Gilead Sciences, Inc. Company Summary
7.1.2 Gilead Sciences, Inc. Business Overview
7.1.3 Gilead Sciences, Inc. T-Cell Therapy Major Product Offerings
7.1.4 Gilead Sciences, Inc. T-Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Gilead Sciences, Inc. Key News & Latest Developments
7.2 Sorrento Therapeutics
7.2.1 Sorrento Therapeutics Company Summary
7.2.2 Sorrento Therapeutics Business Overview
7.2.3 Sorrento Therapeutics T-Cell Therapy Major Product Offerings
7.2.4 Sorrento Therapeutics T-Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Sorrento Therapeutics Key News & Latest Developments
7.3 Fate Therapeutics Inc.
7.3.1 Fate Therapeutics Inc. Company Summary
7.3.2 Fate Therapeutics Inc. Business Overview
7.3.3 Fate Therapeutics Inc. T-Cell Therapy Major Product Offerings
7.3.4 Fate Therapeutics Inc. T-Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Fate Therapeutics Inc. Key News & Latest Developments
7.4 Novartis International AG
7.4.1 Novartis International AG Company Summary
7.4.2 Novartis International AG Business Overview
7.4.3 Novartis International AG T-Cell Therapy Major Product Offerings
7.4.4 Novartis International AG T-Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Novartis International AG Key News & Latest Developments
7.5 AbbVie Inc.
7.5.1 AbbVie Inc. Company Summary
7.5.2 AbbVie Inc. Business Overview
7.5.3 AbbVie Inc. T-Cell Therapy Major Product Offerings
7.5.4 AbbVie Inc. T-Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 AbbVie Inc. Key News & Latest Developments
7.6 Adaptimmune Therapeutics PLC
7.6.1 Adaptimmune Therapeutics PLC Company Summary
7.6.2 Adaptimmune Therapeutics PLC Business Overview
7.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Major Product Offerings
7.6.4 Adaptimmune Therapeutics PLC T-Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Adaptimmune Therapeutics PLC Key News & Latest Developments
7.7 Bluebird Bio
7.7.1 Bluebird Bio Company Summary
7.7.2 Bluebird Bio Business Overview
7.7.3 Bluebird Bio T-Cell Therapy Major Product Offerings
7.7.4 Bluebird Bio T-Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Bluebird Bio Key News & Latest Developments
7.8 TCR2 Therapeutics, Inc.
7.8.1 TCR2 Therapeutics, Inc. Company Summary
7.8.2 TCR2 Therapeutics, Inc. Business Overview
7.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Major Product Offerings
7.8.4 TCR2 Therapeutics, Inc. T-Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 TCR2 Therapeutics, Inc. Key News & Latest Developments
7.9 Pfizer Inc.
7.9.1 Pfizer Inc. Company Summary
7.9.2 Pfizer Inc. Business Overview
7.9.3 Pfizer Inc. T-Cell Therapy Major Product Offerings
7.9.4 Pfizer Inc. T-Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Pfizer Inc. Key News & Latest Developments
7.10 DiaCarta, Inc.
7.10.1 DiaCarta, Inc. Company Summary
7.10.2 DiaCarta, Inc. Business Overview
7.10.3 DiaCarta, Inc. T-Cell Therapy Major Product Offerings
7.10.4 DiaCarta, Inc. T-Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 DiaCarta, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. T-Cell Therapy Market Opportunities & Trends in Global Market
Table 2. T-Cell Therapy Market Drivers in Global Market
Table 3. T-Cell Therapy Market Restraints in Global Market
Table 4. Key Players of T-Cell Therapy in Global Market
Table 5. Top T-Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global T-Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global T-Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies T-Cell Therapy Product Type
Table 9. List of Global Tier 1 T-Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T-Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global T-Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - T-Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - T-Cell Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global T-Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - T-Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - T-Cell Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global T-Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global T-Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global T-Cell Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America T-Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe T-Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia T-Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America T-Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa T-Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 30. Gilead Sciences, Inc. Company Summary
Table 31. Gilead Sciences, Inc. T-Cell Therapy Product Offerings
Table 32. Gilead Sciences, Inc. T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Gilead Sciences, Inc. Key News & Latest Developments
Table 34. Sorrento Therapeutics Company Summary
Table 35. Sorrento Therapeutics T-Cell Therapy Product Offerings
Table 36. Sorrento Therapeutics T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Sorrento Therapeutics Key News & Latest Developments
Table 38. Fate Therapeutics Inc. Company Summary
Table 39. Fate Therapeutics Inc. T-Cell Therapy Product Offerings
Table 40. Fate Therapeutics Inc. T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Fate Therapeutics Inc. Key News & Latest Developments
Table 42. Novartis International AG Company Summary
Table 43. Novartis International AG T-Cell Therapy Product Offerings
Table 44. Novartis International AG T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis International AG Key News & Latest Developments
Table 46. AbbVie Inc. Company Summary
Table 47. AbbVie Inc. T-Cell Therapy Product Offerings
Table 48. AbbVie Inc. T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. AbbVie Inc. Key News & Latest Developments
Table 50. Adaptimmune Therapeutics PLC Company Summary
Table 51. Adaptimmune Therapeutics PLC T-Cell Therapy Product Offerings
Table 52. Adaptimmune Therapeutics PLC T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Adaptimmune Therapeutics PLC Key News & Latest Developments
Table 54. Bluebird Bio Company Summary
Table 55. Bluebird Bio T-Cell Therapy Product Offerings
Table 56. Bluebird Bio T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Bluebird Bio Key News & Latest Developments
Table 58. TCR2 Therapeutics, Inc. Company Summary
Table 59. TCR2 Therapeutics, Inc. T-Cell Therapy Product Offerings
Table 60. TCR2 Therapeutics, Inc. T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. TCR2 Therapeutics, Inc. Key News & Latest Developments
Table 62. Pfizer Inc. Company Summary
Table 63. Pfizer Inc. T-Cell Therapy Product Offerings
Table 64. Pfizer Inc. T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Inc. Key News & Latest Developments
Table 66. DiaCarta, Inc. Company Summary
Table 67. DiaCarta, Inc. T-Cell Therapy Product Offerings
Table 68. DiaCarta, Inc. T-Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. DiaCarta, Inc. Key News & Latest Developments
List of Figures
Figure 1. T-Cell Therapy Segment by Type in 2022
Figure 2. T-Cell Therapy Segment by Application in 2022
Figure 3. Global T-Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global T-Cell Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global T-Cell Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by T-Cell Therapy Revenue in 2022
Figure 8. By Type - Global T-Cell Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global T-Cell Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global T-Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global T-Cell Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global T-Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global T-Cell Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global T-Cell Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America T-Cell Therapy Revenue Market Share, 2018-2030
Figure 16. US T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe T-Cell Therapy Revenue Market Share, 2018-2030
Figure 20. Germany T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia T-Cell Therapy Revenue Market Share, 2018-2030
Figure 28. China T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America T-Cell Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa T-Cell Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. Gilead Sciences, Inc. T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sorrento Therapeutics T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Fate Therapeutics Inc. T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis International AG T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. AbbVie Inc. T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Adaptimmune Therapeutics PLC T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bluebird Bio T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. TCR2 Therapeutics, Inc. T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Inc. T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. DiaCarta, Inc. T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
